Wan X - Search Results

1

MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.

Fu F, Wan X, Wang D, Kong Z, Zhang Y, Huang W, Wang C, Wu H, Li Y. Fu F, et al. Among authors: wan x. Oncotarget. 2017 Dec 6;9(2):1931-1943. doi: 10.18632/oncotarget.23026. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416742 Free PMC article.

2

Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer.

Mo W, Zhang J, Li X, Meng D, Gao Y, Yang S, Wan X, Zhou C, Guo F, Huang Y, Amente S, Avvedimento EV, Xie Y, Li Y. Mo W, et al. Among authors: wan x. PLoS One. 2013;8(2):e56592. doi: 10.1371/journal.pone.0056592. Epub 2013 Feb 22. PLoS One. 2013. PMID: 23451058 Free PMC article.

3

Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.

Li X, Wan X, Chen H, Yang S, Liu Y, Mo W, Meng D, Du W, Huang Y, Wu H, Wang J, Li T, Li Y. Li X, et al. Among authors: wan x. Clin Cancer Res. 2014 May 1;20(9):2312-25. doi: 10.1158/1078-0432.CCR-13-1588. Epub 2014 Mar 7. Clin Cancer Res. 2014. PMID: 24610824

4

KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.

Yang S, Zhang J, Zhang Y, Wan X, Zhang C, Huang X, Huang W, Pu H, Pei C, Wu H, Huang Y, Huang S, Li Y. Yang S, et al. Among authors: wan x. Prostate. 2015 Jun 15;75(9):936-46. doi: 10.1002/pros.22977. Epub 2015 Mar 1. Prostate. 2015. PMID: 25728837

5

MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation.

Li J, Wan X, Qiang W, Li T, Huang W, Huang S, Wu D, Li Y. Li J, et al. Among authors: wan x. Int J Clin Exp Med. 2015 Apr 15;8(4):5329-39. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131109 Free PMC article.

6

A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.

Meng D, Yang S, Wan X, Zhang Y, Huang W, Zhao P, Li T, Wang L, Huang Y, Li T, Li Y. Meng D, et al. Among authors: wan x. Int J Biochem Cell Biol. 2016 Apr;73:30-40. doi: 10.1016/j.biocel.2016.01.018. Epub 2016 Jan 28. Int J Biochem Cell Biol. 2016. PMID: 26827675

7

UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy.

Wan X, Yang S, Huang W, Wu D, Chen H, Wu M, Li J, Li T, Li Y. Wan X, et al. J Exp Clin Cancer Res. 2016 Feb 17;35:34. doi: 10.1186/s13046-016-0308-0. J Exp Clin Cancer Res. 2016. PMID: 26884069 Free PMC article.

8

Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.

Wan X, Pu H, Huang W, Yang S, Zhang Y, Kong Z, Yang Z, Zhao P, Li A, Li T, Li Y. Wan X, et al. Oncotarget. 2016 Aug 9;7(32):51284-51300. doi: 10.18632/oncotarget.9992. Oncotarget. 2016. PMID: 27323416 Free PMC article.

9

Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.

Zhang Y, Zhang P, Wan X, Su X, Kong Z, Zhai Q, Xiang X, Li L, Li Y. Zhang Y, et al. Among authors: wan x. Biomed Pharmacother. 2016 Oct;83:936-941. doi: 10.1016/j.biopha.2016.08.013. Epub 2016 Aug 11. Biomed Pharmacother. 2016. PMID: 27522256

10

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.

Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu F, Huang Y, Wu H, Li T, Li Y. Wan X, et al. Oncotarget. 2016 Sep 13;7(37):60503-60518. doi: 10.18632/oncotarget.11391. Oncotarget. 2016. PMID: 27556357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,162 results

Search Page

Filters